Literature DB >> 7691722

Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.

A Mishra1, K V Rao, H Durgapal, V Manivel, S K Panda.   

Abstract

Hepatitis B virus surface antigen peptide OS (aa124-147) self oligomerizes to form conformational B-cell immunogen with several properties of a candidate peptide vaccine. It gives a T-cell blastogenic response in vaccinated as well as naturally infected individuals. To study the nature and localization of the T-helper cell epitopes, the T-lymphocyte proliferative responses in humans exposed to hepatitis B surface antigen (HBsAg) were examined with a synthetic peptide representing residues 124-147 of this antigen [peptide OS (aa24-147)]. Positive responses were obtained in most cases regardless of whether HBsAg exposure was due to vaccination or a hepatitis B viral infection. Epitope localization studies with truncated peptides indicated the presence of more than two HBsAg-relevant T-helper cell epitopes. This was also corroborated by our fine mapping studies which revealed that the amino acid residues crucial for eventual T-helper cell activation were diverse amongst the various individuals. Together these studies suggest that immunization with peptide OS (aa124-147) may result in an HBsAg cross-reactive T-helper cell response in a broad spectrum of the human population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691722      PMCID: PMC1421980     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of hepatitis B surface antigen.

Authors:  V Manivel; R Ramesh; S K Panda; K V Rao
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

2.  Macromolecular self-association of a synthetic peptide derived from the hepatitis B surface antigen: construction of a quaternary epitope.

Authors:  K V Rao; S K Panda; V Manivel
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

3.  Identification of a new group-specific determinant on hepatitis B surface antigen with a synthetic peptide.

Authors:  V Manivel; S K Panda; K V Rao
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

4.  Design and synthesis of a self-assembling peptide derived from the envelope proteins of HIV type 1. An approach to heterovalent immunogens.

Authors:  S P Tripathy; A Kumar; V Manivel; S K Panda; K V Rao
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

Review 5.  Interactions between immunogenic peptides and MHC proteins.

Authors:  J B Rothbard; M L Gefter
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 6.  The cell biology of antigen processing and presentation.

Authors:  F M Brodsky; L E Guagliardi
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

7.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding.

Authors:  R N Germain; L R Hendrix
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

8.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

9.  Identification of two promiscuous T cell epitopes from tetanus toxin.

Authors:  P C Ho; D A Mutch; K D Winkel; A J Saul; G L Jones; T J Doran; C M Rzepczyk
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

10.  Immune response to hepatitis B virus surface antigen peptides during HBV infection.

Authors:  A Mishra; H Durgapal; V Manivel; S K Acharya; K V Rao; S K Panda
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

View more
  2 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants.

Authors:  Xin Wang; Wanyan Deng; Keli Qian; Haijun Deng; Yong Huang; Zeng Tu; Ailong Huang; Quanxin Long
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-08       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.